CTN NIDA-CTN-0134 Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates)
LaTrice Montgomery, Ph.D. , T. John Winhusen, Ph.D. Jun 03, 2025
CTN NIDA-CTN-0105 Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders
Li-Tzy Wu, ScD. May 23, 2025
CTN NIDA-CTN-0095A1 Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder
Gavin Bart, Ph.D., M.D. , Rebecca Rossom, M.D., M.S. Apr 22, 2025
CTN NIDA-CTN-0083 Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services (Social Media PrEP)
Jeffrey D. Klausner, M.D. Apr 09, 2025
CTN NIDA-CTN-0069 Opioid Use Disorder in the Emergency Department (ED-HEALTH)
David A. Fiellin, M.D. , Gail D'Onofrio, M.D., M.S. Mar 21, 2025
CTN NIDA-CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT)
Adam Bisaga, M.D. , Edward V. Nunes, M.D. Feb 11, 2025
CTN NIDA-CTN-0081 Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO)
Arjun Krishna Venkatesh, MD, MBA, MHS , Kathryn Hawk, M.D., M.H.S. , Richard Andrew Taylor, MD, MHS Dec 06, 2024
CTN NIDA-CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)
John Rotrosen, M.D. , Kathryn Hawk, M.D., M.H.S. , Ryan McCormack, M.D. Nov 04, 2024
CTN NIDA-CTN-0064 Assessing Long-term CTN-0049 Outcomes, HCV Prevalence and Progression along the HCV Care Continuum among HIV/HCV Co-infected Substance Users in the U.S.
Carlos del Rio, M.D. , Carmen Masson, Ph.D. , Daniel J. Feaster, Ph.D. , David Perlman, M.D. , Lisa Metsch, Ph.D. Oct 24, 2024
CTN NIDA-CTN-0095A2 Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians
Stephanie Hooker, Ph.D., M.P.H. , Rebecca Rossom, M.D., M.S. , A. Lauren Crain, Ph.D. , Gavin Bart, Ph.D., M.D. May 24, 2024
CTN NIDA-CTN-0055 Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)
P. Todd Korthuis, MD Mar 07, 2024
CTN NIDA-CTN-0051A2 Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051
John Rotrosen, M.D. Feb 15, 2024
CTN NIDA-CTN-0067 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
P. Todd Korthuis, MD Jul 26, 2023
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
Gerald Cochran, PhD , T. John Winhusen, Ph.D. Apr 13, 2023
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder
Li-Tzy Wu, ScD. , Paolo Mannelli, MD Feb 16, 2023
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2)
Madhukar H. Trivedi, M.D. Oct 07, 2022
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT)
Walter Ling, M.D. Oct 09, 2020
CTN NIDA-CTN-0049 Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Lisa Metsch, Ph.D. , Carlos del Rio, M.D. Sep 07, 2018
CTN NIDA-CTN-0053 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT)
Kevin M. Gray, MD Jul 13, 2018
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
John Rotrosen, M.D. Jan 12, 2018
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study
Robert P Schwartz, M.D. , Li-Tzy Wu, ScD. , Jennifer McNeely, M.D. Sep 14, 2017
CTN NIDA-CTN-0056 Testing and Linkage to HIV Care in China: A Cluster Randomized Trial
Zunyou Wu, MD, PhD Sep 14, 2017
CTN NIDA-CTN-0017 HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings
Robert Booth, Ph.D. Dec 23, 2008
CTN NIDA-CTN-0047 Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)
Michael P. Bogenschutz, M.D. , Dennis Donovan, Ph.D. Sep 02, 2014
CTN NIDA-CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
Donald A. Calsyn, Ph.D. Oct 02, 2008
CTN NIDA-CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
T. John Winhusen, Ph.D. May 14, 2014
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
Walter Ling, M.D. Apr 24, 2015
CTN NIDA-CTN-0046 Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Nov 19, 2013
CTN NIDA-CTN-0044 Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
Edward V. Nunes, M.D. May 14, 2014
CTN NIDA-CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE)
Madhukar H. Trivedi, M.D. Apr 24, 2015
CTN NIDA-CTN-AWARE Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. – an Adaptation of CTN-0032
Lisa Metsch, Ph.D. , Grant Colfax, M.D. Jul 03, 2014
CTN NIDA-CTN-0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.
Lisa Metsch, Ph.D. Nov 02, 2011
CTN NIDA-CTN-0031A An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Nov 26, 2013
CTN NIDA-CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Dennis Donovan, Ph.D. , Dennis Daley, Ph.D. Feb 06, 2012
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence)
Roger Weiss, M.D. , Jennifer Sharpe Potter, Ph.D. Aug 22, 2014
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence
Walter Ling, M.D. , Roger Weiss, M.D. Jun 22, 2011
CTN NIDA-CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Dec 15, 2009
CTN NIDA-CTN-0028 Osmotic-Release Methylphenidate (OROS-MPH) for ADHD in Adolescents with Substance Use Disorders
Paula Riggs, M.D. Oct 04, 2010
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
Walter Ling, M.D. Jun 06, 2012
CTN NIDA-CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
Kathleen Carroll, Ph.D. , José Szapocznik, Ph.D. Jul 30, 2008
CTN NIDA-CTN-0020 Job Seekers Training for Patients with Drug Dependence
Dace Svikis, Ph.D. Feb 27, 2009
CTN NIDA-CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
Susan Tross, Ph.D. Oct 28, 2008
CTN NIDA-CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment
Robert Forman, Ph.D. Aug 01, 2007
CTN NIDA-CTN-0015 Women's Treatment for Trauma and Substance Use Disorders
Denise Hien, Ph.D. May 01, 2009
CTN NIDA-CTN-0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers
José Szapocznik, Ph.D. Mar 02, 2010
CTN NIDA-CTN-0013 Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users
T. John Winhusen, Ph.D. May 27, 2008
CTN NIDA-CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
Lawrence Brown, Jr., M.D., M.P.H. Jun 11, 2007
CTN NIDA-CTN-0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities
Robert L. Hubbard, Ph.D., M.B.A. May 18, 2007
CTN NIDA-CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults
George Woody, M.D. Jul 30, 2009
CTN NIDA-CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs
Malcolm Reid, Ph.D. Dec 03, 2007
CTN NIDA-CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
Dennis McCarty, Ph.D. Jan 25, 2007
CTN NIDA-CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Maxine Stitzer, Ph.D. Dec 13, 2006
CTN NIDA-CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Maxine Stitzer, Ph.D. Oct 31, 2006
CTN NIDA-CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Kathleen Carroll, Ph.D. Sep 08, 2006
CTN NIDA-CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Kathleen Carroll, Ph.D. Oct 03, 2007
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
Walter Ling, M.D. May 29, 2008
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
Walter Ling, M.D. Jul 26, 2006
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification
Walter Ling, M.D. May 08, 2006
